Quarterly Results Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Mar'26
Dec'25
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Net Sales
582.64
432.27
418.33
386.19
563.78
537.78
458.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
582.64
432.27
418.33
386.19
563.78
537.78
458.03
Raw Material Cost
225.76
209.42
203.46
191.42
185.45
247.30
213.97
Purchase of Finished goods
8.73
2.14
23.26
21.82
-16.27
7.87
98.10
(Increase) / Decrease In Stocks
48.53
-38.90
-16.95
-43.84
109.57
6.25
-83.10
Employee Cost
45.05
43.38
43.41
41.26
43.37
41.63
37.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.01
0.01
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
141.44
113.92
90.43
80.28
96.03
106.12
97.66
Total Expenditure (Excl Depreciation)
469.51
329.96
343.62
290.95
418.15
409.17
364.36
Operating Profit (PBDIT) excl Other Income
113.13
102.31
74.71
95.24
145.63
128.61
93.67
Other Income
8.05
-0.37
0.05
1.60
-1.61
5.03
4.48
Operating Profit (PBDIT)
121.18
101.94
74.76
96.84
144.02
133.64
98.15
Interest
16.86
12.58
10.67
6.79
6.58
9.97
5.51
Exceptional Items
0.00
-2.79
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
104.32
86.57
64.09
90.05
137.44
123.67
92.64
Depreciation
28.16
28.62
24.77
22.79
22.82
23.04
20.88
Profit Before Tax
81.68
62.87
38.69
65.45
114.62
100.63
71.77
Tax
20.55
14.91
10.77
15.95
26.28
26.64
17.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
55.61
43.04
28.56
51.30
88.34
73.99
54.62
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
55.61
43.04
28.56
51.30
88.34
73.99
54.62
Share in Profit of Associates
5.51
4.92
-0.64
-1.80
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
61.12
47.96
27.92
49.50
88.34
73.99
54.62
Equity Capital
45.33
45.32
45.32
45.32
45.32
45.31
45.31
Face Value
5.0
5.0
5.0
5.0
5.0
5.0
5.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
6.74
5.29
3.08
5.46
9.75
8.16
6.03
Diluted Earnings per share
6.74
5.29
3.08
5.46
9.74
8.16
6.02
Operating Profit Margin (Excl OI)
19.42%
23.67%
17.86%
24.66%
25.83%
23.91%
20.45%
Gross Profit Margin
17.9%
20.03%
15.32%
23.32%
24.38%
23.0%
20.23%
PAT Margin
10.49%
11.09%
6.67%
12.82%
15.67%
13.76%
11.92%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Mar 2026 is 34.79% vs 3.33% in Dec 2025
Consolidate Net Profit
QoQ Growth in quarter ended Mar 2026 is 27.44% vs 71.78% in Dec 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Mar 2026 is 10.58% vs 36.94% in Dec 2025
Interest
QoQ Growth in quarter ended Mar 2026 is 34.02% vs 17.90% in Dec 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
Compare Quarterly Results Of Aarti Pharma With
Figures in Cr
Consolidate Quarterly Results
Change(INR)
Change(%)
Net Sales
582.64
584.79
-2.15
-0.37%
Other Operating Income
0.00
0.00
0.00
Total Operating income
582.64
584.79
-2.15
-0.37%
Raw Material Cost
225.76
148.93
76.83
51.59%
Purchase of Finished goods
8.73
41.78
-33.05
-79.10%
(Increase) / Decrease In Stocks
48.53
14.90
33.63
225.70%
Employee Cost
45.05
109.30
-64.25
-58.78%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
141.44
163.52
-22.08
-13.50%
Total Expenditure (Excl Depreciation)
469.51
478.43
-8.92
-1.86%
Operating Profit (PBDIT) excl Other Income
113.13
106.36
6.77
6.37%
Other Income
8.05
49.89
-41.84
-83.86%
Operating Profit (PBDIT)
121.18
156.25
-35.07
-22.44%
Interest
16.86
1.55
15.31
987.74%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
104.32
154.70
-50.38
-32.57%
Depreciation
28.16
14.35
13.81
96.24%
Profit Before Tax
81.68
140.35
-58.67
-41.80%
Tax
20.55
36.95
-16.40
-44.38%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
55.61
103.40
-47.79
-46.22%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
55.61
103.40
-47.79
-46.22%
Share in Profit of Associates
5.51
0.00
5.51
Minority Interest
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
61.12
103.40
-42.28
-40.89%
Equity Capital
45.33
16.28
29.05
178.44%
Face Value
5.00
1.00
0.00
Reserves
0.00
0.00
0.00
Earnings per share (EPS)
6.74
6.35
0.39
6.14%
Diluted Earnings per share
6.74
6.35
0.39
6.14%
Operating Profit Margin (Excl OI)
19.42%
18.19%
0.00
1.23%
Gross Profit Margin
17.90%
26.45%
0.00
-8.55%
PAT Margin
10.49%
17.68%
0.00
-7.19%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Quarterly - Net Sales
Net Sales 582.64 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 34.79% vs 3.33% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 3.35% vs 11.47% in Mar 2025
Quarterly - Consolidate Net Profit
Consolidate Net Profit 61.12 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 27.44% vs 71.78% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -30.81% vs 35.39% in Mar 2025
Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 113.13 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 10.58% vs 36.94% in Dec 2025
YoY Growth in quarter ended Mar 2026 is -22.32% vs 23.93% in Mar 2025
Quarterly - Interest
Interest 16.86 Cr
in Mar 2026Figures in Cr
QoQ Growth in quarter ended Mar 2026 is 34.02% vs 17.90% in Dec 2025
YoY Growth in quarter ended Mar 2026 is 156.23% vs 40.60% in Mar 2025
Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 19.42%
in Mar 2026Figures in %
QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025
YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025
